Sik kensa bilong bel i save kamapim wanem samting?
Ol i save skelim sik bilong man i gat sik kensa bilong bel na tingting na ol i save skelim gut ol samting i kamap long dispela sik.
Ol dokta i save kisim ol dispela marasin long taim stret bilong sik.
Lain American Cancer Society i tok, ol man i gat sik kensa bilong bel i save stap laip inap 5-pela yia, olsem 65 pesen bilong ol man i gat dispela sik.
Tasol long ol man i gat sik kensa bilong bel (stage 1), inap 90 pesen bilong ol i stap laip yet long 5-pela yia, na long ol man i gat sik kensa bilong bel long narapela hap (stage 4) inap 111 pesen bilong ol i stap laip yet long 5-pela yia.
Li YD, Lv Z, Xie HY, Zheng SS: Retinoblastoma binding protein 4 up-regulation is correlated with hepatic metastasis and poor prognosis in colon cancer patients. Hepatobiliary Pancreat Dis Int. 2019, 18 (5): 446-451.
Di W, Li X, Yang Q: Polysaccharide of Lactobacillus casei SB27 reduced colon cancer cell prognosis through mitochondrial damage by upregulation of HINT2. Asia Pac J Clin Oncol. 2022, (): .
Kong D, Li G, Yang Z, Cheng S, Zhang W, Feng L, Zhang K: Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes. BMC Cancer. 2022, 22 (1): 84.
Zeng C, Huang L, Zheng Y, Huang H, Chen L, Chi L: [Expression of transcriptional coactivator with PDZ-binding motif (TAZ) in colon cancer tissues and its clinical significance]. Zhonghua Wei Chang Wai Ke Za Zhi. 2015, 18 (11): 1154-7.
Tang S, Yuan X, Song J, Chen Y, Tan X, Li Q: Association analyses of the JAK/STAT signaling pathway with the progression and prognosis of colon cancer. Oncol Lett. 2019, 17 (1): 159-164.
Wang GQ, Lu ZH, Fang YJ, Chen G, Zhou ZW, Pan ZZ, Wan DS: [Expression and clinical significance of survivin and matrix metalloproteinase-7 in colon cancer]. Ai Zheng. 2009, 28 (9): 945-9.
['Toksave: sik']
['Dispela Web-sait i bilong skulim na givim save tasol long ol man, na i no bilong givim tok bilong helpim ol sikman o helpim ol narapela long sait bilong helt.']
['Ol i no ken yusim ol dispela tok bilong helpim ol long save long sik bilong ol, na ol man i laik kisim helpim long ol samting bilong helt, ol i mas toktok wantaim wanpela dokta.']
['Tingim, ol kompiuta i save yusim ol kompiuta long kamapim ol bekim bilong ol askim, tasol ol i no save kolim stret ol namba, olsem namba bilong ol man i gat wanpela sik.']
['Oltaim yu mas kisim tingting bilong dokta o narapela lain i gat save long helpim yu long sait bilong helt sapos yu gat sik. No ken sakim tok bilong dokta o wet long kisim tingting bilong dokta, long wanem, yu ritim sampela tok long dispela Web-sait. Sapos yu ting yu gat sik, ringim 911 o go long haus sik i stap klostu.']
['Toksave: raits bilong man i bosim']
['Digital Millennium Copyright Act bilong 1998, 17 U.S.C. § 512 (the DMCA) i tok ol papa bilong ol samting i gat rait long wokim ol samting, sapos ol i ting ol samting i stap long Intenet i brukim ol lo bilong ol long Amerika.']
['Sapos yu bilip olsem sampela samting i stap long dispela Web-sait o ol sevis bilong mipela i brukim lo bilong kopirait bilong yu, yu (o agent bilong yu) inap salim toksave long mipela na askim mipela long rausim o pasim rot bilong yu long kisim dispela samting.']
['Ol i mas salim ol toksave long rot bilong e-mail (lukim hap "Kontek" bilong lukim e-mail atres). ']
['Lo bilong DMCA i tok olsem toksave bilong yu long ol man i bin brukim lo bilong kopirait i mas i gat ol dispela tok: (1) stori long ol samting i gat kopirait long en, em ol man i tok ol i bin brukim; (2) stori long ol samting i gat kopirait na ol tok bilong helpim mipela long painim ol dispela samting; (3) ol tok bilong yu bilong salim pas long mipela, olsem atres, telefon namba, na e-meil atres; (4) tok yu bin mekim olsem yu bilip tru olsem man i gat kopirait o agent bilong em i no orait long ol samting i stap long dispela websait.']
['(5) Yu mas raitim wanpela pepa na putim han bilong yu bilong tokaut olsem ol tok bilong dispela pepa i stret na yu gat namba long mekim ol samting bilong lukautim ol rait bilong man i bin wokim ol samting.']
['Na (6) wanpela sain o sain bilong man i gat rait long wokim dispela samting o bilong wanpela man i gat namba long mekim wok bilong dispela man.']
['Sapos yu no raitim olgeta dispela tok, dispela inap mekim na ol i no stretim kwik komplen bilong yu.']
['Kontektim']
['Plis salim e-mail long mipela sapos yu gat sampela askim o tingting.']
What is prognosis of colon cancer?
The prognosis of colon cancer depends on several factors, including the stage of the cancer, the patient's age and overall health, and the effectiveness of treatment.
In general, the earlier the cancer is detected and treated, the better the prognosis.
According to the American Cancer Society, the 5-year relative survival rate for colon cancer is about 65% for all stages combined.
However, for localized colon cancer (stage 1), the 5-year relative survival rate is about 90%, while for distant (stage 4) colon cancer, the 5-year relative survival rate is about 111%. It is important to note that these are only estimates and that individual outcomes may vary.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Klostu']
['BioMedLib i yusim ol kompiuta (machine-learning algorithms) long kamapim ol askim na bekim.']
['Pastaim mipela i skelim 35 milion buk bilong ol saientis long ol buk na nius bilong ol dokta na saientis long ol marasin bilong ol man.']
